InvestorsHub Logo
Followers 48
Posts 128
Boards Moderated 0
Alias Born 03/02/2021

Re: exwannabe post# 755511

Thursday, 03/20/2025 7:07:49 PM

Thursday, March 20, 2025 7:07:49 PM

Post# of 759624
I'm not about to try to convince you or anyone else that they should give credence to my observations; everyone reading this is free to draw their own conclusions about the motivations and relative trustworthiness of anonymous message board posters. But I would like to point out that you have left out the context of each of these quotes.

The first quote is from a post on 10/24/24. This was more than a month before the June CHM minutes were released, in which we first learned the date of DCVax-L's first meeting. The post spells out the assumptions upon which my projections were given.

The second quote is from a post on 12/31/24. In context, you'll see that this specifically refers to the fact that there was less lead time between the submission of DCVax-L's MAA and its first CHM meeting than there was for other drugs. This is a true statement.

The third quote is from a post on 2/4/25. The timeframe mentioned in it refers to something I mentioned in another post on the same day, in which I gave a specific date (5/6/25) after which our application would officially be in unprecedented territory. I stand by that date as a point at which I personally would begin to feel worried about how long it was taking (even though, since that time, mRESVIA received approval with an even longer timeline).

Over the past ~4 months, new information has periodically emerged via CHM minutes and MHRA approvals. I don't change my statements because things "looked dark" – I update my observations when new information is available, and acknowledge errors when I make them. To each their own, but that is the approach I personally prefer to take, as opposed to omitting details in order to make a point.
Volume: -
Day Range:
Bid: 0.1925
Ask: 0.2066
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News